CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 5
  • Adult patients
  • Acute viral infection, especially herpes zoster
  • Primary care patient
  • Eligible for add-on therapy with vitamin C
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00921934
NCT00921934N/ACompleted

PASCORBIN 7.5g in the Treatment of Viral Infection, Especially Varicella Zoster Infection: An Observational Cohort Study

Pascoe Pharmazeutische Praeparate GmbH·observational·Posted Jun 17, 2009·Updated Dec 21, 2017

In Brief

An observational study for Virus Diseases and Herpes Zoster. Completed, enrolled 68 participants across 1 site.

Detailed Summary

Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative stress may be of benefit for the patient to prevent further diseases. Shingles (herpes zoster infection) have been successfully treated with antioxidative substances like high-dose vitamin C for ages. Not only the acute symptoms can be diminished by high-dose vitamin C. Even long-term sequelae, like painful post-herpetic neuropathy, may be mitigated or even fully avoided.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 17, 2009
Enrollment StartApr 1, 2009
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.0 years ago